CLINICALLY ADJUSTED VERSUS THERAPEUTIC DRUG MONITORING DOSING REGIMENS WITH ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SERENE-CD MAINTENANCE STUDY

Silvio Danese  ¹     William Sandborn  ²     Edward V. Loftus Jr.  ³     Stephen B Hanauer  ⁴     Stefan Schreiber  ⁵     Laurent Peyrin-Biroulet  ⁶     Remo Panaccione     Julian Panés     Filip Baert     Jean-Frederic Colombel     Marc Ferrante     Edouard Louis     Alessandro Armuzzi     Sasikiran Goteti     John Liu     Nael M. Mostafa     Thao Doan     Joel Petersson     Anne M. Robinson    
¹ Humanitas Research Hospital,Rozzano,Italy
² University of California San Diego,La Jolla,United States
³ Mayo Clinic,Rochester,United States
⁴ Feinberg School of Medicine, Northwestern University,Chicago,United States
⁵ Universität Kiel UKSH,Kiel,Germany
⁶ Nancy University Hospital Inserm U954 Department of Hepato-Gastroenterology,Vandoeuvr

Session
IBD: Drug monitoring

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)